Radiological Evolution of Fat Graft Used for Optic Neuropexy During Surgery for Parasellar Meningiomas.


Journal

Neurosurgery
ISSN: 1524-4040
Titre abrégé: Neurosurgery
Pays: United States
ID NLM: 7802914

Informations de publication

Date de publication:
01 06 2023
Historique:
received: 22 08 2022
accepted: 08 11 2022
pmc-release: 20 01 2024
medline: 17 5 2023
pubmed: 27 1 2023
entrez: 26 1 2023
Statut: ppublish

Résumé

Stereotactic radiosurgery (SRS) is an effective adjuvant therapy for residual tumor after subtotal resection of parasellar meningiomas. Fat graft placement between the optic nerve/chiasm and residual tumor (optic neuropexy [OPN]) allows for safe SRS therapy. To evaluate the radiological temporal profile of the fat graft after OPN, immediately after surgery and at 3, 6, and 12 months intervals, to elucidate the optimal time point of adjuvant SRS. A single-center, retrospective, cohort study of 23 patients after surgery for parasellar meningioma was conducted. Fat graft volume and MRI signal ratios were calculated. SRS dosimetric parameters (tumor/optic nerve) were measured at the time of SRS and compared with a hypothetical dosimetric plan based on an early postoperative MRI. Of 23 patients, 6 (26%) had gross total resection and 17 (74%) had subtotal resection. Fat grafts showed a progressive loss of volume and signal ratio over time. Radiosurgery was performed in 14 (82.3%; 8 hypofractionated radiosurgery and 6 single fraction). At 3 months, there is a loss of 46% of the fat volume and degradation of its tissue intensity, decreasing differentiation from tumor and nerve. The hypothetical treatment plan (performed on an early postoperative MRI) showed that single-fraction SRS would have been possible in 6 of the 8 hypofractionated cases. OPN is a technique that can be safely performed after resection of parasellar meningiomas. Because of the reduction of the fat volume and tissue differentiation between fat and tumor/nerves, adjuvant radiosurgery is better performed within the first 3 months after surgery.

Sections du résumé

BACKGROUND
Stereotactic radiosurgery (SRS) is an effective adjuvant therapy for residual tumor after subtotal resection of parasellar meningiomas. Fat graft placement between the optic nerve/chiasm and residual tumor (optic neuropexy [OPN]) allows for safe SRS therapy.
OBJECTIVE
To evaluate the radiological temporal profile of the fat graft after OPN, immediately after surgery and at 3, 6, and 12 months intervals, to elucidate the optimal time point of adjuvant SRS.
METHODS
A single-center, retrospective, cohort study of 23 patients after surgery for parasellar meningioma was conducted. Fat graft volume and MRI signal ratios were calculated. SRS dosimetric parameters (tumor/optic nerve) were measured at the time of SRS and compared with a hypothetical dosimetric plan based on an early postoperative MRI.
RESULTS
Of 23 patients, 6 (26%) had gross total resection and 17 (74%) had subtotal resection. Fat grafts showed a progressive loss of volume and signal ratio over time. Radiosurgery was performed in 14 (82.3%; 8 hypofractionated radiosurgery and 6 single fraction). At 3 months, there is a loss of 46% of the fat volume and degradation of its tissue intensity, decreasing differentiation from tumor and nerve. The hypothetical treatment plan (performed on an early postoperative MRI) showed that single-fraction SRS would have been possible in 6 of the 8 hypofractionated cases.
CONCLUSION
OPN is a technique that can be safely performed after resection of parasellar meningiomas. Because of the reduction of the fat volume and tissue differentiation between fat and tumor/nerves, adjuvant radiosurgery is better performed within the first 3 months after surgery.

Identifiants

pubmed: 36700760
doi: 10.1227/neu.0000000000002351
pii: 00006123-202306000-00013
pmc: PMC10150850
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1208-1215

Informations de copyright

Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the Congress of Neurological Surgeons.

Références

Starnoni D, Tuleasca C, Giammattei L, et al. Surgical management of anterior clinoidal meningiomas: consensus statement on behalf of the EANS skull base section. Acta Neurochir (Wien). 2021;163(12):3387-3400.
Park KJ, Kano H, Iyer A, et al. Gamma Knife stereotactic radiosurgery for cavernous sinus meningioma: long-term follow-up in 200 patients. J Neurosurg. Published online ahead of print July 1, 2018. DOI: 10.3171/2018.2.JNS172361.
doi: 10.3171/2018.2.JNS172361
Lieber BA, Rodgers S, Kondziolka D, Sen C, Narayana A, Jafar JJ. Intraoperative fat placement in surgically refractory parasellar neoplasms to facilitate stereotactic radiosurgery. Acta Neurochir (Wien). 2014;156(10):1947-1951.
Couldwell WT, Rosenow JM, Rovit RL, Benzil DL. Hypophysopexy technique for radiosurgical treatment of cavernous sinus pituitary adenoma. Pituitary. 2002;5(3):169-173.
Liu JK, Schmidt MH, MacDonald JD, Jensen RL, Couldwell WT. Hypophysial transposition (hypophysopexy) for radiosurgical treatment of pituitary tumors involving the cavernous sinus. Technical note. Neurosurg Focus. 2003;14(5):e11-e15.
Mayo C, Martel MK, Marks LB, Flickinger J, Nam J, Kirkpatrick J. Radiation dose-volume effects of optic nerves and chiasm. Int J Radiat Oncol Biol Phys. 2010;76(3 suppl):S28-S35.
Tuleasca C, Leroy HA, Regis J, Levivier M. Gamma Knife radiosurgery for cervical spine lesions: expanding the indications in the new era of Icon. Acta Neurochir (Wien). 2016;158(11):2235-2236.
Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry. 1957;20(1):22-39.
Hasseleid BF, Meling TR, Ronning P, Scheie D, Helseth E. Surgery for convexity meningioma: Simpson Grade I resection as the goal: clinical article. J Neurosurg. 2012;117(6):999-1006.
Meling TR, Da Broi M, Scheie D, Helseth E. Meningiomas: skull base versus non-skull base. Neurosurg Rev. 2019;42(1):163-173.
Starnoni D, Tuleasca C, Levivier M, Daniel RT. Surgery for clinoidal meningiomas with cavernous sinus extension: near-total excision and chiasmopexy. Acta Neurochir (Wien). 2022;164(9):2511-2515.
Giammattei L, Starnoni D, Levivier M, Messerer M, Daniel RT. Surgery for clinoidal meningiomas: case series and meta-analysis of outcomes and complications. World Neurosurg. 2019;129:e700-e717.
Dufour H, Muracciole X, Metellus P, Regis J, Chinot O, Grisoli F. Long-term tumor control and functional outcome in patients with cavernous sinus meningiomas treated by radiotherapy with or without previous surgery: is there an alternative to aggressive tumor removal? Neurosurgery. 2001;48(2):285-296; discussion 294-296.
DeMonte F, Smith HK, al-Mefty O. Outcome of aggressive removal of cavernous sinus meningiomas. J Neurosurg. 1994;81(2):245-251.
O'Sullivan MG, van Loveren HR, Tew JM Jr. The surgical resectability of meningiomas of the cavernous sinus. Neurosurgery. 1997;40(2):238-247; discussion 245-247.
Pichierri A, Santoro A, Raco A, Paolini S, Cantore G, Delfini R. Cavernous sinus meningiomas: retrospective analysis and proposal of a treatment algorithm. Neurosurgery. 2009;64(6):1090-1101; discussion 1099-1101.
Nakamura M, Roser F, Jacobs C, Vorkapic P, Samii M. Medial sphenoid wing meningiomas: clinical outcome and recurrence rate. Neurosurgery. 2006;58(4):626-639; discussion 626-639.
Puzzilli F, Ruggeri A, Mastronardi L, Agrillo A, Ferrante L. Anterior clinoidal meningiomas: report of a series of 33 patients operated on through the pterional approach. Neuro Oncol. 1999;1(3):188-195.
Risi P, Uske A, Tribolet ND. Meningiomas involving the anterior clinoid process. Br J Neurosurg. 1994;8(3):295-305.
Jesús OD, Sekhar LN, Parikh HK, Wright DC, Wagner DP. Long-term follow-up of patients with meningiomas involving the cavernous sinus: recurrence, progression, and quality of life. Neurosurgery. 1996;39(5):915-920; discussion 919-920.
Goldbrunner R, Minniti G, Preusser M, et al. EANO guidelines for the diagnosis and treatment of meningiomas. Lancet Oncol. 2016;17(9):e383-e391.
Leroy HA, Tuleasca C, Reyns N, Levivier M. Radiosurgery and fractionated radiotherapy for cavernous sinus meningioma: a systematic review and meta-analysis. Acta Neurochir (Wien). 2018;160(12):2367-2378.
Peciu-Florianu I, Regis J, Levivier M, Dedeciusova M, Reyns N, Tuleasca C. Trigeminal neuralgia secondary to meningiomas and vestibular schwannoma is improved after stereotactic radiosurgery: a systematic review and meta-analysis. Stereotact Funct Neurosurg. 2021;99(1):6-16.
Leavitt JA, Stafford SL, Link MJ, Pollock BE. Long-term evaluation of radiation-induced optic neuropathy after single-fraction stereotactic radiosurgery. Int J Radiat Oncol Biol Phys. 2013;87(3):524-527.
Marchetti M, Bianchi S, Pinzi V, et al. Multisession radiosurgery for sellar and parasellar benign meningiomas: long-term tumor growth control and visual outcome. Neurosurgery. 2016;78(5):638-646.
Conti A, Pontoriero A, Iati G, et al. Image-guided multisession radiosurgery of skull base meningiomas. Cancers (Basel). 2020;12(12):3569.
Conti A, Senger C, Acker G, et al. Correction to: normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis. Radiat Oncol. 2020;15(1):279.
Alfredo C, Carolin S, Guliz A, et al. Normofractionated stereotactic radiotherapy versus CyberKnife-based hypofractionation in skull base meningioma: a German and Italian pooled cohort analysis. Radiat Oncol. 2019;14(1):201.
Combs SE, Adeberg S, Dittmar JO, et al. Skull base meningiomas: long-term results and patient self-reported outcome in 507 patients treated with fractionated stereotactic radiotherapy (FSRT) or intensity modulated radiotherapy (IMRT). Radiother Oncol. 2013;106(2):186-191.
Combs SE, Farzin M, Boehmer J, et al. Clinical outcome after high-precision radiotherapy for skull base meningiomas: pooled data from three large German centers for radiation oncology. Radiother Oncol. 2018;127(2):274-279.
Tsukiyama A, Hattori Y, Tahara S, et al. New technique for chiasmapexy using iliac crest bone graft: 2 cases of visual impairment caused by empty sella syndrome. World Neurosurg. 2017;107:1051.e19-1051.e25.
Cossu G, Turin-Huet V, Garvayo Navarro M, et al. Radiological evolution of autograft fat used for skull base reconstruction after transsphenoidal surgery for pituitary adenomas. Pituitary. 2022;25(3):468-473.
Sekhar LN, Patel S, Cusimano M, Wright DC, Sen CN, Bank WO. Surgical treatment of meningiomas involving the cavernous sinus: evolving ideas based on a ten year experience. Acta Neurochir Suppl. 1996;65:58-62.
Faramand A, Kano H, Niranjan A, et al. Cranial nerve outcomes after primary stereotactic radiosurgery for symptomatic skull base meningiomas. J Neurooncol. 2018;139(2):341-348.
Minniti G, Osti MF, Niyazi M. Target delineation and optimal radiosurgical dose for pituitary tumors. Radiat Oncol. 2016;11(1):135.
Kondziolka D, Shin SM, Brunswick A, Kim I, Silverman JS. The biology of radiosurgery and its clinical applications for brain tumors. Neuro Oncol. 2015;17(1):29-44.
Kondziolka D, Niranjan A, Lunsford LD, Flickinger JC. Radiobiology of radiosurgery. Prog Neurol Surg. 2007;20:16-27.
Larson DA, Flickinger JC, Loeffler JS. The radiobiology of radiosurgery. Int J Radiat Oncol Biol Phys. 1993;25(3):557-561.
Bladowska J, Bednarek-Tupikowska G, Sokolska V, et al. MRI image characteristics of materials implanted at sellar region after transsphenoidal resection of pituitary tumours. Pol J Radiol. 2010;75(2):46-54.
Kremer P, Forsting M, Hamer J, Sartor K. MR enhancement of the internal auditory canal induced by tissue implant after resection of acoustic neurinoma. AJNR Am J Neuroradiol. 1998;19(1):115-118.
Weissman JL, Hirsch BE, Fukui MB, Rudy TE. The evolving MR appearance of structures in the internal auditory canal after removal of an acoustic neuroma. AJNR Am J Neuroradiol. 1997;18(2):313-323.
Kamal N, Reddy RK, Kohli G, et al. The role of fast imaging employing steady-state acquisition (FIESTA) magnetic resonance imaging for assessment of delayed enhancement of fat graft packing on postoperative imaging after vestibular schwannoma surgery. World Neurosurg. 2018;114:e1066-e1072.
Nishimura T, Hashimoto H, Nakanishi I, Furukawa M. Microvascular angiogenesis and apoptosis in the survival of free fat grafts. Laryngoscope. 2000;110(8):1333-1338.
Tervala TV, Gronroos TJ, Hartiala P, et al. Analysis of fat graft metabolic adaptation and vascularization using positron emission tomography-computed tomographic imaging. Plast Reconstr Surg. 2014;133(2):291-299.

Auteurs

Simon Diaz (S)

Department of Neurosurgery, University Hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Daniele Starnoni (D)

Department of Neurosurgery, University Hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Constantin Tuleasca (C)

Department of Neurosurgery, University Hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.
Signal Processing Laboratory (LTS 5), Ecole Polytechnique Fédérale de Lausanne (EPFL) Lausanne, Lausanne, Switzerland.

Vincent Dunet (V)

Department of Medical Radiology, University Hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

David Peters (D)

Department of Neurosurgery, University Hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Mahmoud Messerer (M)

Department of Neurosurgery, University Hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Marc Levivier (M)

Department of Neurosurgery, University Hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Roy Thomas Daniel (RT)

Department of Neurosurgery, University Hospital of Lausanne and Faculty of Biology and Medicine, University of Lausanne, Lausanne, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH